United States · Series D startup

Who invested in Auxilium Pharmaceuticals

One round we have observed, with the 8 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Funding summaryUpdated 26 Oct 2026

$43Mraised across 1 round since 2003, from 1 source

Latest round
Series D, $43MNov 2003
Investors
8
See who backed them

The rounds

  1. Nov 2003

Exits

ExitBuyerPriceWhen
AcquiredEndo Health Solutions$2.6BOct 2014
IPONASDAQ:AUXLundisclosedDec 2007

From historical deal records. Wrong? Tell us.

Everyone who backed them

OrbiMedPrivate equity1round
Lehman BrothersHedge fund1round
Sprout GroupGrowth equity1round
BB Biotech VenturesGrowth equity1round
Schroder VenturesPrivate equity1round
CIP CapitalPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Auxilium Pharmaceuticals

Who invested in Auxilium Pharmaceuticals?

Auxilium Pharmaceuticals's investors include OrbiMed, Lehman Brothers, Sprout Group, BB Biotech Ventures and Schroder Ventures, and 3 more on record.

How much has Auxilium Pharmaceuticals raised?

Auxilium Pharmaceuticals has raised $43M across 1 round since 2003.

When did Auxilium Pharmaceuticals last raise?

Auxilium Pharmaceuticals's most recent round was a Series D of $43M in Nov 2003.

What was Auxilium Pharmaceuticals's biggest round?

Its most recent round, $43M in Nov 2003, is also its largest on record.

Who backed Auxilium Pharmaceuticals first?

Auxilium Pharmaceuticals's first round on record, in Nov 2003, was backed by OrbiMed, Lehman Brothers and Sprout Group and 5 others.

What stage is Auxilium Pharmaceuticals at?

Auxilium Pharmaceuticals's latest named round is a Series D, in Nov 2003.

Where is Auxilium Pharmaceuticals based?

Auxilium Pharmaceuticals is based in the United States.

Companies like Auxilium Pharmaceuticals

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.